Experienced in Exercise-Induced Anaphylaxis (EIA)

Dr. Kevin W. Parks

Allergy and Immunology
Allergy And Asthma Center Of Southern Oregon, PC
2628 Clover St, 
Klamath Falls, OR 
 (1790.2 mi)
Accepting New Patients
Experienced in Exercise-Induced Anaphylaxis (EIA)
Allergy And Asthma Center Of Southern Oregon, PC
2628 Clover St, 
Klamath Falls, OR 
 (1790.2 mi)
OverviewInsuranceLocationsClinical Research

Overview

Kevin Parks is an Allergy and Immunologist in Klamath Falls, Oregon. Dr. Parks and is rated as an Experienced provider by MediFind in the treatment of Exercise-Induced Anaphylaxis (EIA). His top areas of expertise are Sinusitis, Allergic Rhinitis, Leukocyte Adhesion Deficiency Type 1, and ICF Syndrome. Dr. Parks is currently accepting new patients.

His clinical research consists of participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of California, San Diego School Of Medicine
Specialties
Allergy and Immunology
Licenses
Allergy & Immunology in OR
Hospital Affiliations
Curry General Hospital
Mercy Medical Center
Sky Lakes Medical Center
Asante Three Rivers Medical Center
Asante Rogue Regional Medical Center
Languages Spoken
English
Spanish
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  BridgeSpan
  •  PacificSource
  •  Moda Health
  •  Regence
  •  Prominence Health

Locations

ALLERGY AND ASTHMA CENTER OF SOUTHERN OREGON, PC
2628 Clover St, Klamath Falls, OR 97601
Other Locations
ALLERGY AND ASTHMA CENTER OF SOUTHERN OREGON, PC
1813 W Harvard Ave, Suite 241, Roseburg, OR 97471
ALLERGY AND ASTHMA CENTER OF SOUTHERN OREGON, PC
3860 Crater Lake Ave, Suite A, Medford, OR 97504

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III, Randomized, Controlled, Observer-blind Study to Demonstrate Effectiveness, Immunogenicity and Safety of GSK's Meningococcal Group B and Combined ABCWY Vaccines When Administered to Healthy Adolescents and Young Adults
A Phase III, Randomized, Controlled, Observer-blind Study to Demonstrate Effectiveness, Immunogenicity and Safety of GSK's Meningococcal Group B and Combined ABCWY Vaccines When Administered to Healthy Adolescents and Young Adults
Enrollment Status: Completed
Publish Date: March 05, 2024
Intervention Type: Combination product, Biological
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
Enrollment Status: Completed
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 09, 2022
Intervention Type: Other, Biological
Study Drugs: Lebrikizumab, Topical Corticosteroid
Study Phase: Phase 3
View 2 Less Clinical Trials

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile